139 results on '"Ferrara, Anne Lise"'
Search Results
2. Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps
3. TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD
4. Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function
5. Thymic stromal lymphopoietin (TSLP) is a substrate for tryptase in patients with mastocytosis
6. Inflammation in cardio-oncology: beyond immunotherapies
7. Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies
8. Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction
9. Innate Immune Cells in Melanoma: Implications for Immunotherapy.
10. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis
11. Roles of Immune Cells in Hereditary Angioedema
12. Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency
13. Altered levels of phospholipases C, diacylglycerols, endocannabinoids, and N‐acylethanolamines in patients with hereditary angioedema due to FXII mutation.
14. Thymic Stromal Lymphopoietin (TSLP) Is Cleaved by Human Mast Cell Tryptase and Chymase.
15. Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
16. The broad spectrum of cardiotoxicities from immunotherapies
17. SARS-CoV-2 Spike Protein Activates Human Lung Macrophages
18. Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function
19. Epigenetics: An opportunity to shape innate and adaptive immune responses
20. PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab
21. Size-based effects of anthropogenic ultrafine particles on activation of human lung macrophages
22. Therapeutic opportunities to modulate immune tolerance through the metabolism-chromatin axis
23. Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
24. Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function.
25. Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects
26. Vascular endothelial growth factors and angiopoietins as new players in mastocytosis. (VARRICCHI AUTORE CORRISPONDENTE)
27. LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation. GALDIERO IS CO-LAST AUTHOR
28. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. (VARRICCHI ULTIMO AUTORE E AUTORE CORRISPONDENTE)
29. Macrophage-polarizing stimuli differentially modulate the inflammatory profile induced by the secreted phospholipase A2 group IA in human lung macrophages. GALDIERO AND FERRARA ARE CO-FIRST AUTHORS
30. Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure. (VARRICCHI PRIMO AUTORE E AUTORE CORRISPONDENTE)
31. PD-L1+ neutrophils as novel biomarkers for stage IV melanoma patients treated with nivolumab.
32. Vascular Endothelial Growth Factors and Angiopoietins As New Players in Mastocytosis
33. Macrophage-polarizing stimuli differentially modulate the inflammatory profile induced by the secreted phospholipase A2 group IA in human lung macrophages
34. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors
35. Role of Vasoactive Mediators in Hereditary Angioedema
36. VEGF-A in Cardiomyocytes and Heart Diseases
37. LPS-mediated neutrophil VEGF-A release is modulated by cannabinoid receptor activation
38. Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure
39. Anaplastic Thyroid Cancer Cells Induce the Release of Mitochondrial Extracellular DNA Traps by Viable Neutrophils
40. Hereditary angioedema attack: what happens to vasoactive mediators?
41. Synthesis and biological evaluation of S-simplexides and other analogues of simplexide
42. Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis
43. LPS‐mediated neutrophil VEGF‐A release is modulated by cannabinoid receptor activation.
44. Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency
45. Potential involvement of neutrophils in human thyroid cancer
46. Neutrophils Involvement in Human Thyroid Cancer
47. Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and -Acylethanolamines in Patients with Mastocytosis.
48. Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency.
49. Epigenetics: An opportunity to shape innate and adaptive immune responses
50. SARS-CoV-2 Spike Protein Activates Human Lung Macrophages
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.